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1. Introduction 
Epidemiological evidence indicates that postprandial hyperglycemia is an independent risk 
factor for cardiovascular disease (Bonora & Muggeo, 2001). Improving postprandial 
glycemic control is considered a target for decreasing the morbidity and mortality due to 
cardiovascular disease in prediabetic and diabetic individuals. Recently, clinical trials such 
as the STOP-NIDDM Trial and Victory Study demonstrated that -glucosidase inhibitors 
(GIs) reduced the progression from impaired glucose tolerance (IGT) to type 2 diabetes 
(Chiasson et al., 2002, 2003; Kawamori et al., 2009). Therefore, considerable attention has 
been paid to GIs as preventive and therapeutic agents for type 2 diabetes and its 
complications. Some food consumed on a daily basis also contains GIs and may therefore 
be effective for attenuating increase in postprandial blood glucose levels. Therefore, 
introducing GIs into the diet may prevent diabetes. 
In Asian countries, mulberry leaves are a known traditional medicine for preventing 
diabetes. According to a prior study, mulberry leaves have a potent GI activity because of 
1-deoxynojirimycin (DNJ), a glucose analog. In this chapter, we describe a method for 
determining DNJ in mulberry leaves; we also describe development of food-grade DNJ-
enriched mulberry leaf extract (ME). Furthermore, we review the efficacy of this extract for 
postprandial glycemic control through human trials aimed at investigating use of mulberry 
leaves as food to prevent diabetes. 
2. Development of ME 
2.1 Diabetes mellitus 
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels. 
Type 2 diabetes, defined as noninsulin-dependent diabetes mellitus (NIDDM), is the most 
common form that affects 90–95 percent of all adults who develop diabetes. Type 2 diabetes 
is a lifestyle disease caused by reduced insulin production or impaired insulin response in 
target organs. It is associated with genetic background, obesity, unhealthy dietary habits, 
and physical inactivity. Hyperglycemia-induced oxidative stress causes serious diabetic 
complications such as diabetic retinopathy, nephropathy, and neuropathy, leading to 
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decreased quality of life. The International Diabetes Federation (IDF) estimates that 285 
million people around the world have diabetes; this total is expected to rise to 438 million 
within 20 years. Each year, a further 7 million people develop diabetes (IDF Diabetes Atlas 
fourth edition committee, 2009). 
Type 2 diabetes increases morbidity and mortality as a result of serious macrovascular 
complications such as cardiovascular disease (Krolewski et al., 1987; Kannel & McGee, 
1979). Recent epidemiological studies suggest that postprandial hyperglycemia is an 
independent risk factor for cardiovascular disease that has a greater effect on the 
development of this disease than fasting hyperglycemia (Ceriello, 1998; Hanefeld et al., 
1996). Therefore, postprandial glycemic control is essential for effective reduction in the risk 
of cardiovascular disease. Carbohydrates comprise about 50% of our daily intake of calories. 
Carbohydrates ingested as food are digested to disaccharides by salivary and pancreatic 
amylases. The disaccharides are then hydrolyzed to monosaccharides by -glucoside at the 
small intestine brush border and absorbed into the blood. -Glucosidase is involved in this 
final step of carbohydrate digestion prior to absorption.GIs retard the digestion and 
absorption of carbohydrates in the small intestinal lumen and therefore reduce the increase 
in blood glucose concentrations after a carbohydrate load. Acarbose, miglitol, and voglibose 
are -glucosidase inhibitory agents used widely in clinical practice. These GIs decrease 
both postprandial hyperglycemia and hyperinsulinemia but do not induce hypoglycemia 
and have a good safety profile, although their gastrointestinal adverse effects may limit 
long-term compliance to therapy. Long-term intervention trials of GIs in patients with type 
2 diabetes and IGT have been conducted. Recent placebo-controlled, prospective trials, 
including the STOP-NIDDM Trial and Victory Study, demonstrated that GI intake before 
each meal reduces the risk of type 2 diabetes in patients with IGT (Chiasson et al., 2002, 
2003; Kawamori et al., 2009). Therefore, improvement in postprandial hyperglycemia by GI 
leads to prevention of diabetes and provides the basis for studies on the use of naturally 
occurringGIs in plant foods. 
2.2 Mulberry 
Mulberry is a tree belonging to the genus Morus of the family Moraceae (Fig. 1). It is 
distributed over a wide area of tropical, subtropical, and temperate zones in Asia, Europe, 
North America, South America, and Africa. There are at least 24 species of mulberry with 
more than 100 known cultivars (Koidzumi, 1917). Historically, the trees have been planted 
for sericulture in east, central, and southern Asia. On the basis of folklore remedies, the 
leaves have also been used as a Chinese herbal tea, especially for diabetes. In the modern 
era, health benefits from mulberry products have been verified scientifically, with mulberry 
shown to have potent -glucosidase inhibitory activity mainly because of azasugars. This 
has led to proposals that dietary mulberry intake is beneficial for attenuating postprandial 
hyperglycemia, thereby preventing diabetes. Several animal studies have been conducted to 
date. Nojima and co-workers showed that administration of mulberry leaf extract restored 
impaired glucose metabolism and hyperglycemic conditions in streptozotocin-induced 
diabetic mice (Nojima et al., 1998; Kimura et al., 1995). At present, various mulberry food 
products, including teas, powders, and tablets, are commercially available in Japan and 
many other countries. Although these products have apparent antidiabetic effects, their 
efficacy in humans requires further study. 
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Fig. 1. Mulberry (Morus alba L.) 
2.3 Azasugars in mulberry 
Azasugars are alkaloids that mimic the structures of monosaccharides. In azasugars, the 
oxygen atom in the ring of these sugars is replaced by nitrogen. The first azasugar, the 
antibiotic nojirimycin, was discovered in 1966 in Streptomyces microorganisms (Inoue et al., 
1966). Since then, more than 100 azasugars have been isolated from plants and 
microorganisms. DNJ is a 5-amino-1,5-dideoxy-D-glucopyranose or D-glucose analog (Fig. 
2). Initially, DNJ was chemically synthesized by reduction of nojirimycin (Inoue et al., 1967) ; 
later, naturally occurring DNJ was isolated from the roots of mulberry trees and called 
moranoline (Yagi et al., 1976). DNJ has also been produced by microorganisms such as 
Bacillus and Streptomyces (Schmidt et al., 1979; Murao & Miyata, 1980; Ezure et al., 1985). 
Mulberry leaves are relatively rich in azasugars such as DNJ, fagomine, N-methyl-DNJ, and 
2-O-R-D-galactopyranosyl-DNJ. DNJ is the dominant alkaloid, accounting for 50% of 
mulberry azasugars (Asano et al., 2001). 
 
NH
OH
HO
HO
OH
O
OH
HO
HO
OH
OH1-deoxynojirimycin
（DNJ) glucose  
Fig. 2. Chemical structure of DNJ and glucose 
Azasugars have -glucosidase inhibitory properties because of their ability to competitively 
bind to the active sites of glucosidases by mimicking the corresponding natural substrates 
(Fig. 3). The GI clinical agents described above are all azasugars developed from natural 
occurring azasugars (Junge et al., 1996). Among the naturally occurring azasugars, DNJ 
shows potent -glucosidase inhibitory activity. Consequently, miglitol was developed as a 
lead compound from DNJ.  
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Based on this background, the relationship between the concentration of DNJ and the 
antidiabetic effect of mulberry food has attracted considerable attention. For this reason, 
mulberry food containing DNJ needs to be prepared. 
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Fig. 3. Possible mechanism of DNJ in the digestive tract 
2.4 Methods for determining DNJ in mulberry 
Determination of DNJ levels in mulberry has been difficult because of the high polarity of 
DNJ and the absence of a chromophore in the molecule. Therefore, DNJ is too hydrophilic to 
be retained by widely used reverse-phase chromatography columns, and it cannot be 
detected with common ultraviolet or fluorescence detectors. Ligand-exchange and 
aminopropyl columns are commonly used for HPLC determination of relatively polar 
compounds such as carbohydrates and water-soluble vitamins (Sharpless et al., 2000). 
However, even these columns do not achieve reasonable retention of DNJ, and for this 
reason, several other methods have been developed for determining DNJ in mulberry.  
Kimura et al. reported a method that used hydrophilic interaction liquid chromatography 
(HILIC) coupled with an evaporative light-scattering detector (ELSD) (Kimura et al., 2004); 
This method is known as the HILIC-ELSD method. HILIC has been developed as an 
efficient tool for analyzing highly hydrophilic compounds, and its analytical application to 
carbohydrates (Alpert et al., 1994) and peptides (Alpert et al., 1990) has been reported. The 
retention ability of the HILIC column basically depends on the hydrophilicity of the 
analytes, and if the compound has amino groups, its retention time is increased (Tolstikov & 
Fiehn, 2002). Therefore, a HILIC column is preferable for efficient separation of azasugars. 
ELSD is the universal detector that responds to nonvolatile compounds and directly detects 
analytes lacking chromophores.  
Kim et al. (2003) reported the procedures for deriving DNJ using 9-
fluorenylmethoxycarbonyl chloride, which targets secondary amino groups in DNJ, 
followed by reverse-phase HPLC using a fluorescence detector. 
Furthermore, several other methods, such as HILIC-MS/MS (Nakagawa et al., 2010) and 
anion-exchange chromatography with pulsed amperometric detection methods (Yoshihashi 
et al., 2010), have been developed for measuring DNJ levels. 
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2.5 Development of ME  
Since the putative effective dose of more than 10 mg DNJ per individual weighing 60 kg 
cannot be generally provided by commercially available mulberry leaf products because of 
their low DNJ content, the development of DNJ-enriched products is highly desired. 
Therefore, to produce nutraceutical ME, the concentrations of DNJ in mulberry leaves from 
different cultivars, harvest seasons, and leaf locations were examined. DNJ concentrations 
differed according to cultivars, with M. alba L. var. Tsuruta and Hayatesakari having a high 
DNJ content. The harvest season and region of mulberry leaves were also closely related to 
the DNJ content, with young mulberry leaves from the top part of the branches in the 
summer having the highest DNJ concentration. After optimization of harvesting and 
processing, ME was produced containing 1.5 % DNJ. This powder contained DNJ at 
concentrations approximately 15 times higher than general mulberry products (Figs. 4, 5; 
Kimura et al., 2007). 
 
Growth for 
mulberry tea
Harvest the DNJ-
enriched leaves
(Usinig plucking machine)
Steam blanching Hot-air drying by 
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Extract with 
80% EtOH
and lyophilize 
Fig. 4. Improved production process for DNJ-enriched mulberry extract (ME) (modified 
from Ref. Kimura, 2010; used with permission) 
Young mulberry leaves from the top part of the branches in August contained the highest 
amount of DNJ. For harvesting, a method involving a plucking machine was considered an 
effective way for collecting young leaves. For blanching, steam treatment was used to 
prevent leaching of DNJ. For the drying process, hot air was employed, and the dried leaves 
were then disintegrated and added to a mixture of ethanol and water (20:80, v:v). After 
filtration, the extract was concentrated and lyophilized to a powder. 
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Fig. 5. DNJ concentrations in mulberry products produced by different processes (modified 
from Ref. Kimura, 2010; used with permission) 
In the traditional process, widely cultivated leaves (M. alba L. var. Kairyou nezumigaeshi) 
were collected from whole branches and dried using hot air. In the improved process, the 
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DNJ content in the extract (M. alba L. var. Kairyou nezumigaeshi) was 15 times higher than 
that in the traditional mulberry product. If mulberry leaves containing high levels of DNJ 
(e.g., M. alba L. var. Tsuruta) were used, products with considerably greater DNJ 
concentrations could be produced. 
3. Evaluation of ME 
3.1 In vitro -glucosidase inhibitory activity 
The rat intestinal -glucosidase inhibitory activity of ME was measured with p-nitrophenyl-
-D-glucopyranoside as the substrate (Yamaki & Mori, 2006). ME showed potent -
glucosidase inhibitory activity, which was approximately the same as the activity of the DNJ 
content in ME. This implied that the -glucosidase inhibitory activity of ME was  
attributable to DNJ. 
3.2 Single oral administration test 
ME showed potent in vitro -glucosidase inhibitory activity. Human intervention trials with 
ME were conducted. To clarify the effect of improving postprandial hyperglycemia and the 
efficacious dose of ME, single oral administration tests were performed. 
3.2.1 Sucrose tolerance test in healthy subjects 
Twenty-four healthy volunteers were randomly divided into four groups of six individuals. 
After fasting overnight, the individuals in each group received either 0 (placebo), 0.4, 0.8, or 
1.2 g ME (corresponding to 0, 6, 12, or 18 mg DNJ, respectively), followed by 50 g sucrose 
dissolved in 100 mL water. Blood samples were collected before and 30, 60, 90, 120, 150, and 
180 min after DNJ or sucrose administration. Plasma glucose and insulin levels were then 
measured. The results showed that oral administration of 0.8 and 1.2 g ME significantly 
suppressed the elevation of postprandial blood glucose and secretion of insulin (Kimura et 
al., 2007). 
3.2.2 Carbohydrate tolerance test in subjects with borderline diabetes 
To examine the diabetes preventative effect of ME in a practical daily meal, a carbohydrate 
tolerance test was performed in subjects with borderline diabetes. The study design was a 
randomized, double-blind, four-period, crossover trial. Twelve volunteers with impaired 
glucose metabolism [fasting plasma glucose (FPG) in the range of 100–140 mg/dL] were 
enrolled in the study. In each trial, all the subjects consumed 200 g boiled white rice 15 min 
after ME ingestion. Blood samples were drawn before ME ingestion and 30, 60, 90, and 120 
min after starting the meal. Plasma glucose, plasma insulin, and other biochemical 
parameters were then measured. Similar to the study described above, administration of 0.8 
and 1.2 g ME caused significant suppression and peak time delay of postprandial blood  
glucose and secretion of insulin (Fig. 6; Asai et al., 2011). 
3.3 Long-term supplementation trial 
Elevation of postprandial blood glucose levels and secretion of insulin were suppressed 
significantly at a dose of more than 0.8 g ME. To assess the safety and effects of long-term 
ingestion, a long-term supplementation trial was then conducted. 
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After fasting for 12 h, the subjects with borderline diabetes were orally administered either 0 (placebo), 
0.4, 0.8, or 1.2 g ME (0, 6, 12, or 18 mg DNJ, respectively), followed by 200 g boiled rice. Blood samples 
were collected prior to intake and 30, 60, 90, and 120 min after rice intake. The plasma glucose and 
insulin levels were then determined. Data represent the mean ± S.E.M. (n = 10). *P < 0.05 vs. placebo. 
Fig. 6. Effects of a single oral administration of ME on plasma glucose (A) and insulin (B) 
levels (from Ref. Asai et al., 2011; used with permission) 
3.3.1 Thirty-eight–day supplementation trial in healthy subjects 
Twelve healthy volunteers were enrolled in the study. Based on the results of the above 
described single oral administration test, the ME dose was set at 1.2 g before every meal. 
The subjects were randomly divided into two groups; they received either 0 (placebo) or 1.2 
g ME before every meal for 38 days (0 or 3.6 g/day, corresponding to 0 and 54 mg DNJ/day, 
respectively). Fasting blood samples were collected on days 0, 24, and 38 of ME powder 
administration. Blood biochemical parameters such as FPG, insulin, glycated hemoglobin 
(HbA1c), triglyceride (TG), total cholesterol (Tcho), HDL cholesterol (HDL-C), adiponectin, 
high-molecular-weight adiponectin (HMW adiponectin), and lipoprotein lipase (LPL) were 
measured. The results showed no significant differences in any of the biochemical 
parameters between the placebo group and the group ingesting the test food either before, 
during, or after the study. The daily intake of the ME powder did not cause hypoglycemia 
or abnormal lipid profiles (i.e., high cholesterol). According to previous reports, long-term 
ingestion of GI (acarbose, tochi extract) reduced FAG, HbA1C, TG, and Tcho levels in the 
subjects (Fujita et al., 2003; Hillerbrand et al., 1979), changes which may contribute to 
diabetes prevention and improvement. The results of our study showed no such effects, 
which could be attributable to the short administration period. The major side effects of GI 
involve the gastrointestinal system (Harano et al., 2002). However, no subjects in our study 
complained of negative gastrointestinal system-related side effects such as abdominal 
distension, abdominal pain, retching, or flatulence (Kimura et al., 2008). 
3.3.2 Twelve-week supplementation trial in subjects with borderline diabetes 
Next, we conducted a 12-week randomized, double-blind, placebo-controlled trial, followed 
by a 4-week posttreatment observation in subjects with borderline diabetes. Seventy-six 
subjects with FPG in the range of 110–140 mg/dL were recruited and randomized to receive 
either mulberry leaf extract or placebo. During the 12-week trial, ME (18 mg DNJ) or 
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identical placebo capsules were taken three times a day before meals. Anthropometric data 
and blood samples were collected from the subjects after they had fasted overnight every 4 
weeks of the supplementation period (week 0, 4, 8, and 12) and 4 weeks after withdrawal of 
the supplementation (week 16). Adverse effects were assessed by interview and self-reports. 
Blood biochemical parameters such as FPG, insulin, HbA1c, glycated albumin (GA), 1,5-
anhydroglucitol (1,5AG), TG, Tcho, HDL-C, adiponectin, HMW adiponectin, and LPL were 
measured.  
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Changes in the concentration of 1,5AG during the 12-week supplementation with either ME (18 mg 
DNJ, thrice daily) or placebo followed by a 4-week observation without supplementation 
Data are expressed as the mean ± S.E.M. (n = 33 in the extract group, n = 32 in the placebo group). *P < 
0.05 vs. placebo. 
Fig. 7. Effects of 12-week supplementation of ME on plasma 1,5AG levels (modified from 
Ref. Asai et al., 2011; used with permission) 
The results showed that there were no significant differences between the ME and placebo 
groups in baseline values or values during the study for the glycemic control parameters 
(FPG, insulin, HbA1c, GA), anthropometric measurements, or serum lipid profiles. Among 
the glycemic control parameters, there were significant differences between the two groups 
with regard to the change in serum 1,5AG concentration over the study period. The 1,5AG 
concentration of the ME group increased gradually from baseline through to weeks 4, 8, and 
12 and was higher than that in the placebo group at weeks 4, 8 and 12. The increase in 1,5AG 
concentration in the ME group returned to the baseline level after the 4-week posttreatment 
observation period (i.e., at week 16) (Fig. 7). The serum 1,5AG concentration is maintained at 
a constant level under euglycemic conditions; however, it decreases as a result of 
competitive inhibition of renal tubular reabsorption caused by glycosuria under 
hyperglycemic conditions (Akanuma et al., 1988; Yamanouchi et al., 1990). Serum 1,5AG 
concentrations therefore sensitively respond to blood glucose fluctuations within a few days 
(Yamanouchi et al., 1992, 1996; Dungan et al., 206). Hence, the increased 1,5AG 
concentration we observed may reflect a continuous reduction in postprandial 
hyperglycemic spikes over the 12-week supplementation period. The increase in the 1,5AG 
concentration returned to baseline levels after the 4-week withdrawal of ME 
supplementation. On the other hand, no significant differences in FPG, HbA1c, or GA 
concentrations were observed between the groups. While the 1,5AG concentration 
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responded to glycemic fluctuations within a few days, the HbA1c and GA concentrations 
reflected time-averaged glycemia in the previous 2–3 months and 2–3 weeks, respectively. 
In contrast to this result, meta-analysis of GI drug trials in patients with type 2 diabetes 
showed that FPG and HbA1c concentrations were reduced by acarbose and miglitol (Van 
Der Laar et al., 2005). Because the subjects in these trials had diabetes, their baseline HbA1c 
and FPG concentrations were considerably higher than those of subjects in the present trial. 
Moreover, these earlier trials were conducted for considerably longer durations. 
Gastrointestinal symptoms such as abdominal distension, diarrhea, and flatulence are the 
most frequent adverse effects of GI agents. No such adverse effects were observed through 
the study period (Asai et al., 2011). 
4. Conclusion 
Increasing evidence strongly supports the efficiency of interventions such as diet and 
exercise for preventing or delaying the onset of diabetes in prediabetic individuals. 
Pharmacological approaches are another effective strategy for achieving these objectives.  
Mulberry leaves have been used in folk medicine for treating diabetes since ancient times. 
Three decades ago, DNJ, a potent GI, was found in mulberry leaves. Since this discovery, 
DNJ has been considered to be responsible for the antidiabetic effect of mulberry leaves. 
However, there is only limited information on the efficacy and effective dose of DNJ in 
humans. Recently, food-grade mulberry leaf extract with a defined DNJ concentration 
(1.5%) has been developed. Human studies involving ingestion of the extract prior to meals 
showed suppression of postprandial hyperglycemia and hyperinsulinemia. In addition, 
studies on long-term supplementation of the extract at reasonable doses showed an 
improvement in postprandial glycemic control. Hypoglycemia; abnormal lipid profiles; 
gastrointestinal system-related side effects such as abdominal distension, abdominal pain, 
retching, or flatulence; or any other adverse effects have also not been observed. Therefore, 
DNJ in mulberry leaves appears to be a promising therapy for preventing or delaying the 
onset of diabetes, especially in prediabetic or mildly diabetic individuals. 
As described above, we have gathered favorable evidence for the efficacy of ME. However, 
in terms of safety, there is insufficient evidence because of a lack of history of mulberry as a 
food for humans. Further safety evaluation on the absorption, distribution, metabolism, and 
excretion of mulberry DNJ is therefore required before the plant can be deployed as a 
functional food. 
5. Acknowledgements 
I would like to give sincere thanks to Professor Miyazawa whose comments and suggestions 
were innumerably valuable throughout my work. Special thanks also go to Associate 
Professor Nakagawa whose meticulous comments were an enormous help to me. 
6. References 
Akanuma, Y.; Morita, M. & Fukuzawa, N. Urinary excretion of 1,5-anhydro-D-glucitol 
accompanying glucose excretion in diabetic patients. Diabetologia, Vol. 31, (1988), 
pp. 831–835, ISSN 0012-186X 
www.intechopen.com
 
Hypoglycemia – Causes and Occurrences 
 
34
Alpert, A. J. Hydrophilic-interaction chromatography for the separation of peptides, nucleic 
acids and other polar compounds. Journal of Chromatography, Vol. 499, (1990), pp. 
177-196, ISSN 0021-9673 
Alpert, A. J.; Shukla, M.; Shukla, AK.; Zieske, LR.; Yuen, SW.; Ferguson, MA. J.; Mehlert, A.; 
Pauly, M. & Orlando, R. Hydrophilic-interaction chromatography of complex 
carbohydrates. Journal of Chromatography A, Vol. 676, (1994), pp. 191-202, ISSN 0021-
9673 
Asai, A.; Nakagawa, K.; Higuchi, O.; Kimura, T.; Kojima, Y.; Kariya, J.; Miyazawa, T. & 
Oikawa, S. Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content 
on postprandial glycemic control in subjects with impaired glucose metabolism. 
Journal of Diabetes Investigation, in press, (2011), ISSN 2040-1116 
Asano, N.; Yamashita, T.; Yasuda, K.; Ikeda, K.; Kizu, H.; Kameda, Y.; Kato, A.; Nash, R. J.; 
Lee, H. S. & Ryu, K. S. Polyhydroxylated alkaloids isolated from mulberry trees 
(Morus alba L.) and silkworms (Bombyx mori L.). Journal of Agricultural and Food 
Chemistry. Vol. 49, (2001), pp. 4208-4213, ISSN 0021-8561 
Bonora, E. & Muggeo, M. Postprandial blood glucose as a risk factor for cardiovascular 
disease in Type II diabetes: the epidemiological evidence. Diabetologia, Vol. 44, 
(2001), pp. 2107–2114, ISSN 0012-186X 
Ceriello, A. The emerging role of post-prandial hyperglycemic spikes in the pathogenesis of 
diabetic complications. Diabetic Medicine, Vol. 15, (1998), pp. 188-193, ISSN 1939-327X 
Chiasson, JL.; Josse. RG. & Gomis, R. Acarbose for prevention of type 2 diabetes mellitus: 
the STOP-NIDDM randomized trial. The Lancet, Vol. 359, (2002), pp. 2072–2077, 
ISSN 0140-6736 
Chiasson, JL.; Josse RG. & Gomis, R. Acarbose treatment and the risk of cardiovascular 
disease and hypertension in patients with impaired glucose tolerance: the STOP-
NIDDM trial. The Journal of the American Medical Association, Vol. 290, (2003), pp. 
486–494, ISSN 0098-7484 
Dungan, KM.; Buse, JB. & Largay, J. 1,5-Anhydroglucitol and postprandial hyperglycemia as 
measured by continuous glucose monitoring system in moderately controlled 
patients with diabetes. Diabetes Care, Vol. 29, (2006), pp. 1214–1219, ISSN 0149-5992 
Ezure, Y.; Murao, S.; Miyazaki, K. & Kawamata, M. Molanoline (1-deoxynojirimycin) 
fermentation and its improvement. Agricultural and biological chemistry, 49, (1985), 
pp. 1119-1125, ISSN 0002-1369 
Fujita, H.; Yamagami, T. & Ohshima, K. Long-term ingestion of Touchi-extract, an α-
glucosidase inhibitor, by borderline and mild type-2 diabetic subjects is safe and 
significantly reduces blood glucose levels. Nutrition Research, Vol. 23, (2003), pp. 
713–722, ISSN 0271-5317 
Hanefeld, M.; Fischer, S.; Julius, U.; Schulze, J.; Schwanebeck, U.; Shmechel, H.; Ziegelasch 
HJ. & Lindner, J. Risk factors for myocardial infarction and death in newly detected 
NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia, Vol. 39, 
(1996), pp. 1577-1583, ISSN 0012-186X 
Harano, Y.; Suzuki, M.; Koyama, Y.; Kanda, M.; Yasuda, S.; Suzuki, K. & Takamizawa, I. 
Multifactorial insulin resistance and clinical impact in hypertension and 
cardiovascular disease. Journal of Diabetes and its Complications, Vol. 16, (2002), pp. 
19– 23, ISSN 1056-8727 
www.intechopen.com
 
Development of Mulberry Leaf Extract for Suppressing Postprandial Blood Glucose Elevation 
 
35 
Hillerbrand, I.; Boehm, K.; Frank, G.; Fink, H. & Berchtoid, P. The effects of the α-
glucosidase inhibitor BAY g5421 (acarbose) on meal stimulated elevations of 
circulating glucose, insulin and triglyceride levels in man, Research in Experimental 
Medicine, Vol. 175, (1979), pp. 81–86, ISSN 0300-9130 
IDF Diabetes Atlas fourth edition committee. (2009), Prevalence estimates of diabetes 
mellitus (DM) 2010 and 2030and, In: Diabetes Atlas, Available from 
http://www.diabetesatlas.org/ 
Inoue, S.; Tsuruoka, T. & Niida, T. The structure of nojirimycin, a piperidinose sugar 
antibiotic. The Journal of Antibiotics, Vol. 19, (1966), pp. 288-292, ISSN 0021-8820 
Inoue, S.; Tsuruoka, T.; Ito, T. & Niida, T. Structure and synthesis of nojirimycin. 
Tetrahedron, Vol. 23, (1967), pp. 2125-2144. 
Junge, B.; Matzke, M. & Stltefuss, J. (1996) Chemistry and structureactivity relationships of 
glucosidase inhibitors. In Handbook of experimental pharmacology, Kuhlmann, J.; Puls, 
W., (Eds.), Vol. 119, pp. 411-482, Springer-Verlag, ISBN 3-540-58990-2, New York, 
USA 
Kannel, W. & McGee, D. Diabetes and cardiovascular risk factors: the Framingham Study. 
Circulation Journal, Vol. 59, (1979), pp. 8-13, ISSN 1346-9843 
Kawamori, R.; Tajima, N.; Iwamoto, Y.; Kashiwagi, A.; Shimamoto, K. & Kaku, K. on behalf 
of the Voglibose Ph-3 Study Group Voglibose for prevention of type 2 diabetes 
mellitus: a randomised, double-blind trial in Japanese individuals with impaired 
glucose tolerance. The Lancet, Vol. 373, No. 9675, (May 2009), pp. 1607- 1614, ISSN 
0140-6736 
Kim, JW.; Kim, S.-U.; Lee, HS.; Kim, I.; Ahn, MY. & Ryu, KS. Determination of 1-
deoxynojirimycin in Morus alba L. leaves by derivatization with 9-fluorenylmethyl 
chloroformate followed by reversed-phase high-performance liquid chromatography. 
Journal of Chromatography A, Vol. 1002, (2003), pp. 93-99, ISSN 0021-9673 
Kimura, M.; Chen, F.-J.; Nakashima, N.; Kimura, I.; Asano, N. & Koya, S. Antihyperglycemic 
effects of N-containing sugars derived from mulberry leaves in streptozotocin-
induced diabetic mice. Journal of Traditional Medicines, Vol. 12, (1995), pp. 214-219 
Kimura, T.; Nakagawa, K.; Saito, Y.; Yamagishi, K.; Suzuki, M.; Yamaki, K.; Shinmoto, H. & 
Miyazawa, T. Determination of 1-deoxynojirimycin in mulberry leaves using 
hydrophilic interaction chromatography with evaporative light scattering 
detection. Journal of Agricultural and Food Chemistry, Vol. 52, (2004), pp. 1415-1418, 
ISSN 0021-8561 
Kimura, T.; Nakagawa, K. & Kubota, H. Food-grade mulberry powder enriched with 1-
deoxynojirimycin suppresses the elevation of postprandial blood glucose in 
humans. Journal of Agricultural and Food Chemistry, Vol. 55, (2007), pp. 5869–5874, 
ISSN 0021-8561 
Kimura, T.; Nakagawa, K.; Kubota, H.; Kojima, Y.; Yamagishi, K.; Oikawa, S. & Miyazawa, 
T. Long term effect of DNJ-enriched mulberry leaf product. Journal of Clinical 
Biochemistry and Nutrition, Supple, Vol. 43, (June 2008), pp. 1–3, ISSN 0912-0009 
Kimura, T. Development of mulberry leaf product with a-glucosidase inhibitor for the 
prevention of type2 diabetes mellitus. Nippon Shokuhin Kagaku KogakuKaishi, Vol. 
57, No. 2, (2010), pp. 57-62 (in Japanese), ISSN 1341-027X 
Koidzumi, G. (1917). Taxonomical discussion on Morus plants. Bull. Imp. Sericult. Exp. Stat., 
Vol. 3, pp. 1-62. (in Japanese)  
www.intechopen.com
 
Hypoglycemia – Causes and Occurrences 
 
36
Krolewski, AS.; Kosinski, EJ.; Warram, JH.; Leland, OS.; Busick, EJ.; Asmal, AC.; Rand, LI.; 
Christlieb, AR.; Bradley, RF. & Kahn, CR. Magnitude and determinants of coronary 
artery disease in juvenile-onset, insulin-dependent diabetes mellitus. American 
Journal of Cardiology, Vol. 59, No. 8, (April 1987), pp. 750-755, ISSN 0002-9149 
Murao, S. & Miyata, S. Isolation and characterization of a new trehalase inhibitor, S-GI. 
Agricultural and biological chemistry, Vol. 44, (1980), pp. 219-221, ISSN 0002-1369 
Nakagawa, K.; Ogawa, K.; Higuchi, O.; Kimura, T.; Miyazawa, T. & Hori, M. Determination 
of iminosugars in mulberry leaves and silkworms using hydrophilic interaction 
chromatography–tandem mass spectrometry. Analytical Biochemistry, Vol. 404, 
(2010), pp. 217–222, ISSN 0003-2697 
Nojima, H.; Kimura, I.; Chen, F.-J.; Sugihara, Y.; Haruno, M.; Kato, A. & Asano, N. 
Antihyperglycemic effects of N-containing sugars from Xanthocercis zambesiaca, 
Morus bombycis, Aglaonema treubii, and Castanospermum australe in 
streptozotocindiabetic mice. Journal of Natural Products, Vol. 61, (1998), pp.397-400, 
ISSN 0974-5211 
Schmidt, DD.; Frommer, W.; Muller, L.;& Truscheit, E. Glucosidase inhibitors from bacilli. 
Naturwissenshaften, Vol. 66, (1979), pp. 584-585, ISSN 0028-1042 
Sharpless, KE.; Margolis, S. & Thomas, JB. Determination of vitamins in food-matrix 
standard reference materials. Journal of Chromatography A, Vol. 881, (2000), pp. 171-
181, ISSN 0021-9673 
Tolstikov, VV. & Fiehn, O. Analysis of highly polar compounds of plant origin: combination 
of hydrophilic interaction chromatography and electrospray ion trap mass 
spectrometry. Analytical Biochemistry, Vol. 301, (2002), pp. 298-307, ISSN 0003-2697 
Yagi, M.; Kouno, T.; Aoyagi, Y. & Murai, H. The structure of Moraoline, a piperidine 
alkaloid from Morus species. Nippon Nougei Kagaku Kaishi, Vol. 50, (1976), pp. 571-
572 (in Japanese), ISSN 0002-1407 
Yamaki, K. & Mori, Y. Evaluation of α-glucosidase Inhibitory activity in colored foods : a 
trial using slope factors of regression curves. Nippon Shokuhin Kagaku Kogaku Kaishi, 
Vol. 53, No. 4, (2006), pp. 229-231 (in Japanese), ISSN 1341-027X 
Yamanouchi, T.; Akaoka, I. & Akanuma, Y. Mechanism for acute reduction of 1, 5-
anhydroglucitol in rats treated with diabetogenic agents. American Journal of 
Physiology, Vol. 258, (1990), pp. E423–E427, ISSN 1522-1466 
Yamanouchi, T.; Moromizato, H. & Shinohara, T. Estimation of plasma glucose fluctuation 
with a combination test of hemoglobin A1c and 1,5-anhydroglucitol. Metabolism, 
Vol. 41, (1992), pp. 862–867, ISSN 1744-6651 
Yamanouchi, T.; Ogata, N. & Tagaya, T. Clinical usefulness of serum 1, 5-anhydroglucitol in 
monitoring glycaemic control. The Lancet, Vol. 347, (1996), pp. 1514–1518, ISSN 
0140-6736 
Yoshihashi, T.; Do, HT.; Tungtrakul, P.; Boonbumrung, S. & Yamaki, K. Simple, selective, and 
rapid quantification of 1-deoxynojirimycin in mulberry leaf products by high-
performance anion-exchange chromatography with pulsed amperometric detection. 
Journal of Food Science, Vol. 75, No. 3, (April 2010), pp. 246-50, ISSN 0022-1147 
Van Der Laar, FA.; Lucassen, PL.& Akkermans, RP. a-Glucosidase inhibitors for patients 
with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. 
Diabetes Care, Vol. 28, (2005), pp. 154–163, ISSN 0149-5992 
www.intechopen.com
Hypoglycemia - Causes and Occurrences
Edited by Prof. Everlon Rigobelo
ISBN 978-953-307-657-7
Hard cover, 238 pages
Publisher InTech
Published online 10, October, 2011
Published in print edition October, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Glucose is an essential metabolic substrate of all mammalian cells being the major carbohydrate presented to
the cell for energy production and also many other anabolic requirements. Hypoglycemia is a disorder where
the glucose serum concentration is usually low. The organism usually keeps the glucose serum concentration
in a range of 70 to 110 mL/dL of blood. In hypoglycemia the glucose concentration normally remains lower
than 50 mL/dL of blood. This book provides an abundance of information for all who need them in order to
help many people worldwide.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Toshiyuki Kimura (2011). Development of Mulberry Leaf Extract for Suppressing Postprandial Blood Glucose
Elevation, Hypoglycemia - Causes and Occurrences, Prof. Everlon Rigobelo (Ed.), ISBN: 978-953-307-657-7,
InTech, Available from: http://www.intechopen.com/books/hypoglycemia-causes-and-
occurrences/development-of-mulberry-leaf-extract-for-suppressing-postprandial-blood-glucose-elevation
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
